Malcolm Wall Media: Media News Page Header Icon

TECHCRUNCH.COM NEWS

Back to home

Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation

Mon, 20 Jul 2026

The de-extinction startup is looking to double or triple its previous valuation, according to the report.
Continue reading...